Guest guest Posted April 6, 2011 Report Share Posted April 6, 2011 Helene The data on FCR shows that it works well in all 11q del. I do not believe node size was teased out as a variable when looking at that data, but I would suggest you read the whole CLL8 trial to see if it buried somewhere Having small nodes can only be good, because big nodes are hard to treat and nodes are where the cancer grows much more so than the marrow or blood One caveat: With 11q del it is very possible to have small or no palpable nodes and big mesenteric (gut) nodes, only seen on CAT scan. That has been my situation twice. Be well On Apr 5, 2011, at 9:45 PM, elmerleb wrote: Does anyone have, or know about, having an 11q deletion with no swollen nodes? Does this just mean very early disease, or do some 11qs not have this manifestation? I am wondering if a) no swelling means a less aggressive version of 11q - is there such a thing? and if FCR is the treatment of choice for 11q, mainly because it is so effective on lymph nodes, does it remain the treatment of choice if the person does not have swollen nodes? Thanks, Heléne Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 7, 2011 Report Share Posted April 7, 2011 Hi Helene, My impression (from remarks made by experts such as Furman and what I've copied below) is that the utility of cytogenetic markers like 11q is not clear... and that classic staging remains the most reliable way to guide decisions in regular clinical practice -- outside of a trial. " As the mysteries of the biology of CLL are revealed, important biological prognostic parameters are claiming a place in the prognostic assessment of the disease. The staging systems developed in the early 1970s have been crucial in the progress of our understanding on CLL. Because of their simplicity and reproducibility they have been widely employed. They have also been critical in conducting randomized treatment studies in comparable series of patients, and in attracting the interest of a new generation of younger physicians and investigators to an old disease. To abandon the clinical staging systems would be not only precipitous, but unwise. Rather than replace clinical stages and other simple prognostic parameters (e.g. degree of bone marrow infiltration, white blood cell count, doubling time), these new factors should currently be employed to refine the prognostic power of classical prognostic factors. Finally, clinical staging systems and other prognostic factors were developed in an era in which no effective therapy existed for CLL. Since prognostic indicators may change as more effective therapies become available, prognosis should be assessed prospectively in patients treated with the newer and more effective therapies. Only in that manner will the most relevant prognostic factors for CLL eventually be identified, a quarter of a century after the introduction of clinical stages. " http://annonc.oxfordjournals.org/content/15/10/1450.full Hope this helps. Karl > > Does anyone have, or know about, having an 11q deletion with no swollen nodes? > Does this just mean very early disease, or do some 11qs not have this manifestation? > I am wondering if a) no swelling means a less aggressive version of 11q - is there such a thing? and if FCR is the treatment of choice for 11q, mainly because it is so effective on lymph nodes, does it remain the treatment of choice if the person does not have swollen nodes? > > Thanks, > > Heléne > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.